Recently, Wada et al. [2] described novel finding pathogenic variants of the GALM gene which encodes galactose mutarotase, the enzyme which catalyzes the epimerization between β and α-D-galactose in the first step of the Leloir pathway in patients with ‘unexplained congenital galactosaemia. The gene discussed is GALM; the disease is galactosemia.